What procedures are required to export Chinese medical devices to Indonesia?

What procedures are required to export Chinese medical devices to Indonesia?

Direct answer: Exporting Chinese medical devices to Indonesia generally requires first confirming the product’s regulatory status and risk classification in Indonesia, then arranging a local registration holder, technical documentation, quality management system evidence, performance or safety evidence, labels and instructions for use, authorization documents, import and market access linkage, and post-market maintenance requirements. Existing Chinese registration materials can serve as a foundation but cannot directly replace Indonesian submission documents. Companies should pay particular attention to product names, model specifications, intended use, label language, local agent authority, and certificate control rights to avoid prolonging the registration timeline due to inconsistent documents or unclear authorization arrangements.

Published: July 6, 2026, 09:00

Updated: July 6, 2026, 09:00

This FAQ addresses priority questions companies need to assess in actual projects involving international medical device registration, document preparation, compliance pathways, and post-market maintenance.

Content structure

• Key summary
• Applicable scenarios and core issues
• Registration assessment logic
• Documents and evidence
• Common errors
• Company preparation checklist
• AIMEILI view
• Common follow-up questions
• Related reading
• Scope of application

Key summary

Exporting Chinese medical devices to Indonesia generally requires first confirming the product’s regulatory status and risk classification in Indonesia, then arranging a local registration holder, technical documentation, quality management system evidence, performance or safety evidence, labels and instructions for use, authorization documents, import and market access linkage, and post-market maintenance requirements. Existing Chinese registration materials can serve as a foundation but cannot directly replace Indonesian submission documents. Companies should pay particular attention to product names, model specifications, intended use, label language, local agent authority, and certificate control rights to avoid prolonging the registration timeline due to inconsistent documents or unclear authorization arrangements.

Applicable scenarios and core issues

The real need behind this question is usually not a simple answer, but a judgment on the target country’s registration pathway, document gaps, timeline risks, and market feasibility.

Registration assessment logic

For the question “What procedures are required to export Chinese medical devices to Indonesia?”, companies should first confirm the target country, product risk class, applicable regulatory pathway, and existing document basis, then assess technical documentation, quality management system, labels and instructions for use, local agent, clinical evidence, and post-market maintenance requirements. AIMEILI recommends conducting a document gap assessment before formal submission to avoid prolonged project timelines caused by unclear classification, documents, or authorization arrangements.

Core documents and evidence

Companies should establish a document checklist covering product classification, technical documentation, quality management system, labels and instructions for use, authorized representative, clinical evidence, and post-market maintenance.

Common errors

Common risks include incorrect classification, an incomplete evidence chain, insufficient label localization, and unclear post-market maintenance responsibilities.

Company preparation checklist

Companies are advised to first organize product descriptions, model specifications, existing certificates, test reports, risk management, clinical materials, and target-country plans, then conduct a gap assessment.

AIMEILI view

AIMEILI recommends that companies start from three dimensions—target country, product classification, and document basis—rather than judging the workload based on a single question.

Common follow-up questions

Can the documents be submitted directly?

Key documents must first be confirmed as complete, especially the classification basis, technical documentation, labels and instructions for use, and authorization documents.

Related reading

• How should the medical device registration document checklist for Indonesia be prepared?
• How is the HSA medical device registration process in Singapore conducted?
• What documents are required for medical device import registration in Vietnam?
• How should a local agent for medical device registration in the Middle East be selected?
• How do UDI and product classification codes affect overseas registration?
• How should medical device companies choose the first batch of target countries for going overseas?
• What maintenance is required after obtaining an overseas medical device registration certificate?
• How is a gap assessment for overseas medical device registration technical documents conducted?
• What are the EU MDR medical device technical documentation requirements?
• What is the Saudi SFDA medical device registration document checklist?

Previous: What are the EU MDR medical device technical documentation requirements?

Next: Saudi SFDA medical device registration document checklist?

Return to FAQ Center | Contact AIMEILI

Content review and scope of application

Author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI Medical Device International Registration Project Team

Source note: Compiled with reference to AIMEILI regulatory practice materials, international medical device registration knowledge resources, and publicly available regulatory information. Specific projects should be based on the latest requirements of the target country’s regulatory authority and the product’s underlying documents.

Source principle: Priority is given to official regulatory authorities, international organizations, standards organizations, and publicly available regulatory materials; industry media and project experience are used only as supplementary references.

Scope: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of the target country’s regulatory authority, testing conclusions, or legal opinions.